Dostarlimab-gxly, GlaxoSmithKline, Jemperli
Dostarlimab-gxly ine chemotherapy inotenderwa neFDA kune endometrial cancer
Nyamavhuvhu 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline), ichiteverwa nedostarlimab-gxly semumiriri mumwe chete, yakabvumidzwa neFood and Drug Administration kurapwa kwegomarara rekutanga kana rekare reendometrial (EC.
dMMR, Dostarlimab-gxly, GlaxoSmithKline, Jemperli
Dostarlimab-gxly inotenderwa neFDA kune dMMR endometrial cancer
Kukadzi 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) yakapihwa mvumo yeFDA yekurapa varwere vakura vane kusawirirana kwekugadzirisa kushomeka (dMMR) inodzokororwa kana yepamberi endometrial cancer iyo yakawedzera panguva kana mushure mekare.
dostarlimab, Gina Kolata, GlaxoSmithKline, Luis A. Diaz Mwana, NEJM
Vese vatori vechikamu mukuyedza kenza diki vakawana kuregererwa kwakakwana
Chikumi 2022: Chidzidzo chidiki chevarwere vegomarara rectal chakaburitsa zvinoshamisa: 100 muzana yevanhu vaive mukuregererwa. Mhedzisiro yacho yakaburitswa muThe New England Journal of Medicine svondo rino.Kuyedzwa kwakapihwa mari ..